Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CTV 05

Drug Profile

CTV 05

Alternative Names: CTV-05; LACTIN-V; Lactobacillus crispatus CTV-05

Latest Information Update: 31 Aug 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GyneLogix
  • Developer National Institute of Allergy and Infectious Diseases; Osel Inc; The Fertility Clinic, Skive; University of Washington
  • Class Probiotics
  • Mechanism of Action Bacteria replacements; Vaginal microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Urinary tract infections
  • Phase II Bacterial vaginosis

Most Recent Events

  • 16 Aug 2023 The Fertility Clinic, Skive completes the phase II trial inBacterial vaginosis in Denmark (Vaginal) (NCT05166746) (EudraCT2016-002385-31)
  • 10 May 2021 Phase-II clinical trials in Bacterial vaginosis in South Africa (Vaginal) (NCT05022212)
  • 03 Feb 2021 Osel enters into a clinical trial licensing agreement with Danish Research Consortia (comprising Aarhus University, Skive Hospital and Statens Serum Institut of Denmark) for LACTIN-V for Bacterial vaginosis
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top